Sequencing Startup IBS Raises Private Cash

IBS has kept a relatively low profile the past couple of years, but it plans to get prototype sequencing systems into the hands of early-access customers as early as the first quartyer of this year.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories